Theratechnologies (NASDAQ:THTX) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.07) by 42.86 percent. This is a 11.11 percent decrease over losses of $(0.09) per share from the same period last year.
Raymond James Maintains Outperform on QCR Holdings, Raises Price Target to $62
Raymond James analyst Daniel Tamayo maintains QCR Holdings (NASDAQ:QCRH) with a Outperform and raises the price target from $60 to $62.
